MedPath

PRENAVITE FORTE

PRENAVITE FORTE

Discontinued
DIN Number

00677116

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

allen & hanburys a glaxo canada ltd. co.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00677116
AIG Number0617811001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
B03AE04 IRON, MULTIVITAMINS AND MINERALS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:04.04
Health Canada Classification

ACTIVE INGREDIENTS (6)

CALCIUM CARBONATEActive
Strength: 125 MG / TAB
Monograph: CALCIUM CARBONATE
FERROUS FUMARATEActive
Strength: 75 MG / TAB
Monograph: FERROUS FUMARATE
FOLIC ACIDActive
Strength: 1 MG / TAB
Monograph: FOLIC ACID
SODIUM ASCORBATEActive
Strength: 100 MG / TAB
Monograph: SODIUM ASCORBATE
VITAMIN A ACETATEActive
Strength: 4000 UNIT / TAB
Monograph: VITAMIN A ACETATE
VITAMIN DActive
Strength: 400 UNIT / TAB
Monograph: VITAMIN D

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.